Profund Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Sell |
23,070
-2,088
| -8% | -$17K | 0.01% | 920 |
|
|
2025
Q1 | $197K | Buy |
25,158
+8,037
| +47% | +$63.1K | 0.01% | 909 |
|
|
2024
Q4 | $255K | Sell |
17,121
-1,599
| -9% | -$23.8K | 0.01% | 861 |
|
|
2024
Q3 | $286K | Sell |
18,720
-1,017
| -5% | -$15.6K | 0.01% | 829 |
|
|
2024
Q2 | $301K | Sell |
19,737
-34,693
| -64% | -$528K | 0.01% | 721 |
|
|
2024
Q1 | $1.03M | Buy |
54,430
+11,265
| +26% | +$213K | 0.04% | 354 |
|
|
2023
Q4 | $824K | Sell |
43,165
-7,906
| -15% | -$151K | 0.04% | 368 |
|
|
2023
Q3 | $917K | Sell |
51,071
-5,325
| -9% | -$95.6K | 0.05% | 306 |
|
|
2023
Q2 | $1.15M | Sell |
56,396
-21,376
| -27% | -$434K | 0.06% | 288 |
|
|
2023
Q1 | $1.42M | Buy |
+77,772
| New | +$1.42M | 0.09% | 196 |
|